Etlinger H M, Knorr R
Central Research Units, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Vaccine. 1991 Jul;9(7):512-4. doi: 10.1016/0264-410x(91)90038-8.
It has been shown that pre-immunization with a protein can inhibit the antibody response to a new B-cell sequence which is coupled to the protein (epitope-specific suppression). By utilizing a peptide with carrier function from the protein, rather than the entire protein, the antibody response to the new B-cell sequence is enhanced in protein-primed mice. The present results extend this observation by showing that mice which have been pre-immunized with a protein followed by a B-cell sequence linked to a carrier peptide from the protein produce an enhanced antibody response to a new B-cell sequence linked to the same carrier peptide sequence. This indicates that it would be possible to reuse a carrier peptide sequence coupled with newly defined protective B-cell epitopes in a given individual to achieve immunity against new pathogens.
已经表明,用一种蛋白质进行预免疫可以抑制对与该蛋白质偶联的新B细胞序列的抗体反应(表位特异性抑制)。通过使用来自该蛋白质的具有载体功能的肽,而不是整个蛋白质,在经蛋白质预免疫的小鼠中,对新B细胞序列的抗体反应增强。目前的结果扩展了这一观察结果,表明先用一种蛋白质进行预免疫,然后用与该蛋白质的载体肽相连的B细胞序列进行免疫的小鼠,对与相同载体肽序列相连的新B细胞序列产生增强的抗体反应。这表明,在给定个体中,可以重复使用与新定义的保护性B细胞表位偶联的载体肽序列,以实现对新病原体的免疫。